Tag: university
-
Neurons Identified, Stimulated for Spinal Cord Repair
Spinal cord injury patients in a clinical trial received electronic stimulation to a specified set of nerve cells that enabled them to restore walking after rehabilitation.
-
Covid-19 Vaccine Patch Clinical Trial Begins
Developers of a patch with tiny needles instead of a syringe to deliver vaccines say a clinical trial testing a Covid-19 patch is now underway in Australia.
-
Trial Shows Results for Personal Cancer Immunotherapies
Interim results from a clinical trial testing personalized therapies invoking the immune system show responses from some patients with advanced liver cancer.
-
AI-Aided System to Identify Diabetes Complication Risks
Researchers at University of Houston are creating a system aided by algorithms for primary care physicians to better identify people at risk for complications from diabetes.
-
Cancer Detection Start-Up Gains $4M in Seed Funds
A developer of early-stage non-invasive cancer detection tests based on research in university labs is raising $4 million in its seed venture round.
-
Dual-Action Vaccine Shown to Attack, Shrink Solid Tumors
Research with lab animals shows an experimental cancer vaccine generates immune-system cells that infiltrate solid tumors and reduce the tumor’s protective environment.
-
Immunotherapy Start-Up Launches Collaboration, Raises $65M
A new biotechnology company is creating cancer immunotherapies that it says harness more of the full power of T-cells in the immune system to attack tumors.
-
Grant Funds Regenerative Gel for Treating Skin Ulcers
A California state research agency is funding preclinical development of a gel designed to regenerate stem cells in the skin to help heal venous skin ulcers.
-
“Dark Genome” Drug Discoverer Gains $37M in Early Funds
19 Oct. 2022. A biotechnology enterprise discovering new drugs from non-protein coding regions of the genome is raising €37.5 million ($US 36.6 million) in venture funds. Nucleome Therapeutics Ltd. in Oxford, U.K. is a three year-old business spun-off from genetic research labs at University of Oxford medical school. Nucleome Therapeutics is seeking new treatments for…
-
Hydrogel Biomaterials Company Raises $3M in Early Funds
A developer of bioactive hydrogels as alternatives to animal models for drug discovery and clinical lab tests is raising $3 million in its first venture round.